IKS NSI Week ended 07 Aug 2026

Weekly Investor Report

INVENTURUS KNOWLEDGE SO L · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 1,738 INR
-6.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 7.9% above the Trend Line and sits at 70.9% of its 52-week range. The latest completed week returned -6.0%, after a -9.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 43/100.

Setup score 51 out of 100
Latest Close 1,738 INR 7 Aug 2026
1W Return -6.0% latest completed week
4W Return -9.9% short-term follow-through
12W Return 8.9% quarterly tape
Trend Breadth 32.7% 17 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • The trend backdrop is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 43.73% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
  • The latest week was a sharp negative move.
  • Latest weekly return ranks in the weaker part of its sector group.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -6.0% Latest completed week; four-week move -9.9%. Indicator stack 39/64 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.73% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 43/100 8 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 7.9% above the Trend Line and sits at 70.9% of its 52-week range. The latest completed week returned -6.0%, after a -9.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7512-week average 0.45

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.75Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -9.9% over four weeks, 8.9% over 12 weeks, and 8.6% over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W-6.0%
4W-9.9%
12W8.9%
26W3.5%
52W8.6%
Active trend streak6 weeks
Active weeks in one year17
Trend breadth32.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.82Latest activity-pressure read.
Pressure change-7.2%Four-week change in activity pressure.
Leadership9.09Latest relative-leadership reading.
RS change-62.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength52/100Blend of value, momentum, and quality. Underlying universe rank 49; rank 1 is best.
Value16/100Relative valuation strength. Underlying universe rank 85; rank 1 is best.
Quality96/100Profitability and accounting quality. Underlying universe rank 5; rank 1 is best.
Momentum75/100Medium-term price momentum. Underlying universe rank 26; rank 1 is best.
Growth87/100Revenue and earnings growth. Underlying universe rank 14; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
42.3x
Price divided by trailing earnings.
Price / sales
9.3x
Market value relative to trailing revenue.
EV / EBITDA
28.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
48.7%
Gross profit retained from each unit of revenue.
Operating margin
29.4%
Operating profit retained from revenue.
Free-cash-flow margin
19.5%
Free cash flow generated from revenue.
Return on invested capital
21.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
19.9%
Latest one-year revenue growth.
EPS growth
48.0%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
122.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.1%
Net share repurchases relative to market value.
Shareholder yield
-0.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment43/100

Weighted news tone is neutral across 8 relevant articles.

1 positive · 5 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.1%Distance below the 52-week high.
13-week volatility4.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+15.1%Week of 1 May.
Worst week-13.7%Week of 27 Feb.
Latest week-6.0%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains6
Flat weeks0
Modest losses10
Sharp losses5
Recent vol4.7%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape52/100

Trend, activity pressure, participation, and risk combine to a 52/100 tape read.

 Indicator analysis70/100

Latest 12-week confirmation: trend 6/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.75; 2 reversal markers Next-Week ExpectancyNegative 43.73%

Next-week expectancy is negative with a 43.73% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors59/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 75 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment43/100

Weighted news tone is neutral across 8 relevant articles.

Inventurus Knowledge Solutions Limited Just Missed EPS By 7.2%: Here's What Analysts Think Will Happen Next Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20261,738 INR-6.0%1,611 INR1,622 INR0.829.091.2MOn
31 Jul 20261,849 INR5.1%1,608 INR1,621 INR1.0017.13458.4KOn
24 Jul 20261,760 INR-7.2%1,602 INR1,618 INR0.9814.74580.8KOn
17 Jul 20261,897 INR-1.6%1,601 INR1,616 INR0.9921.16537.0KOn
10 Jul 20261,928 INR3.6%1,595 INR1,613 INR0.8824.321.6MOn
3 Jul 20261,861 INR9.2%1,585 INR1,609 INR0.7420.29450.5KOn
26 Jun 20261,704 INR1.7%1,578 INR1,606 INR0.6611.610Off
19 Jun 20261,675 INR-0.2%1,577 INR1,605 INR0.6410.15233.1KOff
12 Jun 20261,678 INR1.2%1,574 INR1,604 INR0.5712.3680.5KOff
5 Jun 20261,659 INR-1.0%1,571 INR1,603 INR0.5512.31313.7KOff
29 May 20261,676 INR5.7%1,571 INR1,602 INR0.5712.78766.8KOff
22 May 20261,586 INR-0.6%1,570 INR1,601 INR0.606.31792.4KOff
15 May 20261,595 INR-6.0%1,568 INR1,601 INR0.497.411.7MOff
8 May 20261,696 INR2.5%1,565 INR1,601 INR0.2811.731.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context